Mesoblast R&D Spending Growth & History (MESO)

Mesoblast's r&d spending was $97.5M for fiscal 2026.

View full Mesoblast company overview

Mesoblast annual r&d spending history

Mesoblast annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20262026-06-30$97.5M$62.7M+180.14%
20252025-06-30$34.8M−$4.9M−12.36%
20242024-06-30$39.7M−$13.1M−24.80%
20232023-06-30$52.8M$20.0M+60.95%
20222022-06-30$32.8M−$20.2M−38.10%
20212021-06-30$53.0M−$3.2M−5.65%
20202020-06-30$56.2M−$3.6M−6.06%
20192019-06-30$59.8M−$6.1M−9.27%
20182018-06-30$65.9M$7.0M+11.90%
20172017-06-30$58.9M$8.9M+17.80%
20162016-06-30$50.0M

Mesoblast r&d spending trends

Over the last five fiscal years, Mesoblast's r&d spending increased from $53.0M to $97.5M, a change of $44.5M. The latest reported quarter, Q3 2023, shows $7.1M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Mesoblast source filings ↗

Community posts

It’s quiet here.

No posts about MESO yet. Start the conversation.

Write the first post